Man Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
64,744
+24,123
| +59% | +$760K | ﹤0.01% | 1214 |
|
|
2025
Q1 | $1.33M | Buy |
40,621
+17,057
| +72% | +$559K | ﹤0.01% | 1311 |
|
|
2024
Q4 | $852K | Sell |
23,564
-760
| -3% | -$27.5K | ﹤0.01% | 1386 |
|
|
2024
Q3 | $758K | Buy |
+24,324
| New | +$758K | ﹤0.01% | 1427 |
|
|
2023
Q4 | – | Hold |
0
| – | -$312K | – | 2121 |
|
|
2023
Q3 | – | Sell |
-60,462
| Closed | -$1.82M | – | 1612 |
|
|
2023
Q2 | $1.82M | Buy |
+60,462
| New | +$1.82M | 0.01% | 1214 |
|
|
2023
Q1 | – | Sell |
-40,765
| Closed | -$1.45M | – | 1224 |
|
|
2022
Q4 | $1.45M | Buy |
+40,765
| New | +$1.45M | 0.01% | 1208 |
|
|
2021
Q2 | – | Sell |
-10,900
| Closed | -$285K | – | 2012 |
|
|
2021
Q1 | $285K | Sell |
10,900
-191,628
| -95% | -$5.01M | ﹤0.01% | 1640 |
|
|
2020
Q4 | $5.1M | Sell |
202,528
-50,800
| -20% | -$1.28M | 0.02% | 798 |
|
|
2020
Q3 | $5.28M | Buy |
253,328
+64,655
| +34% | +$1.35M | 0.02% | 782 |
|
|
2020
Q2 | $4.48M | Buy |
188,673
+62,582
| +50% | +$1.49M | 0.02% | 723 |
|
|
2020
Q1 | $2.27M | Buy |
126,091
+9,075
| +8% | +$163K | 0.01% | 831 |
|
|
2019
Q4 | $2.78M | Buy |
117,016
+60,225
| +106% | +$1.43M | 0.01% | 1222 |
|
|
2019
Q3 | $1.56M | Buy |
56,791
+16,411
| +41% | +$451K | 0.01% | 1316 |
|
|
2019
Q2 | $1.34M | Sell |
40,380
-97,077
| -71% | -$3.21M | ﹤0.01% | 1438 |
|
|
2019
Q1 | $4.82M | Buy |
137,457
+131,109
| +2,065% | +$4.59M | 0.02% | 938 |
|
|
2018
Q4 | $211K | Sell |
6,348
-107,662
| -94% | -$3.58M | ﹤0.01% | 1795 |
|
|
2018
Q3 | $5.74M | Sell |
114,010
-54,142
| -32% | -$2.73M | 0.02% | 908 |
|
|
2018
Q2 | $10.1M | Sell |
168,152
-65,062
| -28% | -$3.89M | 0.04% | 574 |
|
|
2018
Q1 | $10.7M | Buy |
+233,214
| New | +$10.7M | 0.05% | 451 |
|